BADGE, a synthetic antagonist for PPARγ, prevents steroid-related osteonecrosis in a rabbit model

Na Yuan1, Jia Li2, Meng Li3

  • 1Department of Ultrasonography, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, 710061, People's Republic of China.

Abstract

Insights

Inhibition of PPARγ using BADGE prevented steroid-induced osteonecrosis in rabbits. This treatment improved bone quality, reduced osteonecrosis, and enhanced bone formation, suggesting a potential therapy.

Area of Science:

  • Biomedical research
  • Orthopedics
  • Pharmacology

Background:

  • Steroid-induced osteonecrosis is a significant clinical challenge.
  • Peroxisome proliferator-activated receptor gamma (PPARγ) inhibition shows promise as a therapeutic strategy.

Purpose of the Study:

  • To investigate the preventive effects of PPARγ inhibition on steroid-related osteonecrosis.
  • To evaluate bisphenol a diglycidyl ether (BADGE) as a PPARγ antagonist in a rabbit model.

Main Methods:

  • Rabbits were divided into normal, model, and BADGE-treated groups.
  • Osteonecrosis was induced, and the BADGE group received a PPARγ antagonist for six weeks.
  • Histopathology, micro-computed tomography, and bone histomorphometry were employed.

Main Results:

  • BADGE treatment significantly reduced osteonecrotic changes and bone marrow adiposity.
  • Improved bone quality, increased femoral blood perfusion, and reduced intraosseous pressure were observed.
  • Enhanced bone formation markers (osteocalcin) and reduced bone resorption markers (TRACP) were noted.

Conclusions:

  • Pharmacological inhibition of PPARγ, using BADGE, effectively prevented steroid-related osteonecrosis in rabbits.
  • These findings support PPARγ inhibition as a potential future therapy for this condition.

Related Concept Videos

Models of Health Promotion and Illness Prevention II01:18

Models of Health Promotion and Illness Prevention II

The person's health status fluctuates continually, varying from being in good health to becoming ill and returning to being healthy. To understand the concept of illness prevention, there are two models. First, the health-illness continuum model is a graphic representation of an individual's wellness. It states that a person is considered healthy in the absence of physical disease and the presence of good emotional health.
The agent-host-environment model states that disease results...
2.2K
Models of Health Promotion and Illness Prevention I01:25

Models of Health Promotion and Illness Prevention I

A model is a theoretical way to understand a concept or an idea. Models can overcome barriers to health regardless of diverse economic and cultural backgrounds. In addition, models make the task easier by providing different ways to approach complex issues. There are two major health promotion models: the health belief model and the health promotion model.
The health belief model (HBM) attempts to predict health-related behavior in specific belief patterns. According to the HBM, a person's...
2.9K
Synthetic Biology02:55

Synthetic Biology

Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...
5.6K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.2K
Cholinergic Antagonists: Pharmacokinetics01:24

Cholinergic Antagonists: Pharmacokinetics

Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations,  while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
990
Cholinergic Antagonists: Therapeutic Uses01:26

Cholinergic Antagonists: Therapeutic Uses

Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal...
1.5K